154 related articles for article (PubMed ID: 3332188)
21. Immunomagnetic purging in autologous bone marrow transplantation: experience in fourteen patients.
Canals C; Puntí C; Picón M; Amill B; Tugues D; Sanchez T; Badell I; Pardo N; Ortega J; Vivancos P
Prog Clin Biol Res; 1992; 377():289-96. PubMed ID: 1438427
[No Abstract] [Full Text] [Related]
22. Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation.
Shpall EJ; Bast RC; Joines WT; Jones RB; Anderson I; Johnston C; Eggleston S; Tepperberg M; Edwards S; Peters WP
Bone Marrow Transplant; 1991 Feb; 7(2):145-51. PubMed ID: 2049558
[TBL] [Abstract][Full Text] [Related]
23. Elimination of malignant clonogenic breast cancer cells from human bone marrow.
Anderson IC; Shpall EJ; Leslie DS; Nustad K; Ugelstad J; Peters WP; Bast RC
Cancer Res; 1989 Aug; 49(16):4659-64. PubMed ID: 2663144
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow transplantation. Separation of stem cells.
Viktora L; Hermanová E; Herzog P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):435-42. PubMed ID: 6182063
[TBL] [Abstract][Full Text] [Related]
25. Processing of bone marrow for transplantation: development of a mononuclear cell enrichment protocol.
Hollingsworth KL; Williams SF; Blake MS; Pothiawala M; Mick R; Larson RA; Bender JG
Prog Clin Biol Res; 1994; 389():695-704. PubMed ID: 7700937
[No Abstract] [Full Text] [Related]
26. The feasibility of peripheral blood stem cell collection for autograft following failure in bone marrow aspiration.
Lefrère F; Hermine O; Audat F; Buzyn A; Cavazzana-Calvo M; Boccaccio C; Varet B
Hematol Cell Ther; 1998 Jun; 40(3):133-7. PubMed ID: 9698222
[TBL] [Abstract][Full Text] [Related]
27. Semiautomated autologous bone marrow processing for transplantation.
Pierelli L; Menichella G; Paoloni A; Serafini R; Vittori M; Foddai ML; Meoni F; Rossi PL; Leone G; Mango G
Haematologica; 1991 Mar; 76 Suppl 1():10-1. PubMed ID: 1677909
[TBL] [Abstract][Full Text] [Related]
28. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
29. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
Broxmeyer HE; Lu L; Platzer E; Feit C; Juliano L; Rubin BY
J Immunol; 1983 Sep; 131(3):1300-5. PubMed ID: 6193183
[TBL] [Abstract][Full Text] [Related]
31. Prediction of engraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony-forming unit-granulocyte-macrophage, or both?
Jansen EM; Hanks SG; Terry C; Akard LP; Thompson JM; Dugan MJ; Jansen J
Transfusion; 2007 May; 47(5):817-23. PubMed ID: 17465946
[TBL] [Abstract][Full Text] [Related]
32. Malignant leukemic cell separation by iron colloid immunomagnetic adsorption.
Biéva CJ; Vander Brugghen FJ; Stryckmans PA
Exp Hematol; 1989 Sep; 17(8):914-20. PubMed ID: 2670597
[TBL] [Abstract][Full Text] [Related]
33. Cryopreservation of marrow, purging and autologous bone marrow transplantation in childhood.
Reiners B; Hermann J; Fuchs D; Prager J; Thränhardt H; Burger E; Kob D; Zintl F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):601-8. PubMed ID: 2480316
[TBL] [Abstract][Full Text] [Related]
34. Improved CFU-GM recoveries from marrows of neuroblastoma patients using a slightly modified immunomagnetic depletion technique.
Lopez M; Martinache C; Bardinet D; Mortel O; Michon J; Combaret V
Bone Marrow Transplant; 1989 Jul; 4(4):453-4. PubMed ID: 2775922
[No Abstract] [Full Text] [Related]
35. Predictive factors for the rate of engraftment of neuroblastoma patients autotransplanted with purged marrow.
Ross RE; Jeter EK; Gazitt Y; Laver J
Prog Clin Biol Res; 1994; 389():139-43. PubMed ID: 7700896
[TBL] [Abstract][Full Text] [Related]
36. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
[TBL] [Abstract][Full Text] [Related]
37. Depletion of neuroblastoma cells from bone marrow with monoclonal antibodies and magnetic immunobeads.
Seeger RC; Reynolds CP; Vo DD; Ugelstad J; Wells J
Prog Clin Biol Res; 1985; 175():443-58. PubMed ID: 3887429
[No Abstract] [Full Text] [Related]
38. Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use.
Kvalheim G; Sørensen O; Fodstad O; Funderud S; Kiesel S; Dörken B; Nustad K; Jakobsen E; Ugelstad J; Pihl A
Bone Marrow Transplant; 1988 Jan; 3(1):31-41. PubMed ID: 3048468
[TBL] [Abstract][Full Text] [Related]
39. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Papadakis V; Ferguson KF; Heller G; Kernan NA
Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
[TBL] [Abstract][Full Text] [Related]
40. [Quantitative detection and elimination of neuroblastoma cells in vitro. Comparative study of the efficacy of an immunomagnetic method and lymphokine-activated killer cells].
Kästli M; Aapro M; Blaser K; Jeannet M; Irlé C
Schweiz Med Wochenschr; 1987 Nov; 117(46):1832-4. PubMed ID: 3321426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
